A brain scan tracer is less exact in later stage tumors in mice
Original title: Allocation of TSPO-PET signals to cellular and extracellular compartments in dependence of blood-brain barrier disruption in experimental glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in mice.
The short version
In mice, a common brain tumor scan was less exact in later stage tumors.
What was studied. Researchers gave a PET scan tracer called TSPO to mice with brain tumors. There were 36 mice with early stage tumors and 39 with late stage tumors. The team then sorted the tumor cells to see where the tracer went.
What they found. In early stage tumors, 72% of the scan signal came from the tracer doing its job. In late stage tumors, that dropped to 59%. The rest of the signal came from a leaky blood brain barrier. When the team looked at single cells, the tracer was very exact.
What this means, and what it doesn't
What it could mean: TSPO PET scans are used to watch brain tumors. This work says part of the scan signal may not come from the tumor itself. Scientists may need to read these scans with more care.
What it doesn't mean: This is not a treatment and not a cure. It was done in mice, not in people. It does not mean PET scans are wrong or should stop. This is early lab work. It is a long way from day to day care.
Source: PubMed, September 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.